Hepatology in Focus
Strategies to Treat Liver Disease, From Traditional to Cutting-Edge
Lifestyle modifications and control of cardiometabolic risk factors are foundational to the management of all patients with MASLD, but some may need more targeted pharmacologic therapy.
AUGUST 26, 2025
Endohepatology: Where Can EUS Take Us?
Endoscopic ultrasound has played an increasingly expanding role in gastrointestinal diagnosis and treatment over the past several years.
AUGUST 22, 2025
Wegovy Approved to Treat MASH With Moderate to Advanced Fibrosis
The FDA has approved semaglutide in conjunction with diet and exercise for the treatment of MASH with moderate to advanced fibrosis.
AUGUST 20, 2025
Addressing Childhood Obesity to Prevent Liver Disease
The hepatology community should “double down” on prevention for adolescents to stave off lifelong liver disease, according to Rohit Kohli, MBBS, MS, a pediatric hepatologist at Children’s Hospital Los Angeles.
AUGUST 12, 2025
Annual Hepatitis Surveillance Report Shows Progress, Opportunities
A newly released CDC report demonstrates that five of 10 indicators assessing progress toward viral hepatitis reduction met annual targets in 2025.
JULY 15, 2025
Senators Introduce Bill Aimed to Support Fight to Cure Hep C
A new bill introduced to the U.S. Senate aims to increase funding and access for hepatitis C virus treatment in the United States.
JUNE 27, 2025
More Data on Role of Statins in Prevention of HCC and Chronic Liver Disease
A new large retrospective study lends further credence to the evolving theory that statins may help prevent hepatocellular carcinoma and chronic liver disease progression.
JUNE 17, 2025
Point-of-Care HCV Test Offers Reliable Screening, Potential to Speed Up Treatment
A novel HCV test showed good diagnostic accuracy in symptomatic and at-risk patients, opening the door for improved receipt of timely treatment compared with the current two-stage testing model.
JUNE 16, 2025
FDA Approves Checkpoint Inhibitor Combination For Unresectable or Metastatic HCC
The FDA has approved nivolumab with ipilimumab for the first-line treatment of adults with unresectable or metastatic hepatocellular carcinoma.
JUNE 11, 2025
Easing Symptom Burden, Improving QOL For Decompensated Cirrhosis Patients
People living with decompensated liver cirrhosis face a substantial symptom burden that can significantly diminish their quality of life.
JUNE 3, 2025
Quality of Life in Children Living With Autoimmune Liver Diseases
Children with autoimmune liver disease and their caregivers face numerous challenges, but their health-related quality of life has not been well studied.
MAY 27, 2025
Expert Picks From The Liver Meeting 2024
In this second part of a two-part series, Ashwani Singal, MD, MS, discusses abstracts on treatment of severe alcohol-associated hepatitis, seladelpar for PBC and GLP-1s for MASLD.
MAY 22, 2025
